SIMILASAN Maux de voyage glob fl 15 g

7680678120014 CH-67812 20.01.1.
SIMILASAN Maux de voyage glob fl 15 g
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6781201
CPT
-
Packaging group
15.0
Unit
g
Composition
nux-vomica (Ph.Eur.Hom.) D15 (Ph.Eur.Hom. 1.1.8) 2.500 mg, hyoscyamus niger (HAB) D15 2.500 mg, petroleum rectificatum (HAB) D15 2.500 mg, anamirta cocculus (HAB) D15 (Ph.Eur.Hom. 1.1.8) 2.500 mg, calcii carbonas, xylitolum 600.00 mg, ad globulos pro 1 g corresp. 70-90 granula homoeopathica imbuta.

Articles (1)

Similasan Reisekrankheit, Globuli
Globuli
15.0
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/05/2022
Patient information leaflet
Français
17/05/2022
Patient information leaflet
Italien
17/05/2022

Detailed composition

Substance Quantity Type Category
nux-vomica (Ph.Eur.Hom.)
2.5 MG Substance Wirkstoff (Principe actif)
hyoscyamus niger (HAB)
2.5 MG Substance Wirkstoff (Principe actif)
petroleum rectificatum (HAB)
2.5 MG Substance Wirkstoff (Principe actif)
anamirta cocculus (HAB)
2.5 MG Substance Wirkstoff (Principe actif)
calcii carbonas
- Substance HNIDK
xylitolum
600.0 MG Substance HNIDK

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
67812
Drug name
Similasan Reisekrankheit, Globuli
Galenic form
GLO
Authorization status
Z
Dispensation category
D
First authorization
16/12/2021
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei Reisekrankheit (Auto, Flugzeug, Schiff, Eisenbahn usw.) mit Symptomen wie Übelkeit, Erbrechen und Schwindelgefühl.

Packaging details

Description (FR)
SIMILASAN Maux de voyage glob fl 15 g
Description (DE)
SIMILASAN Reisekrankheit Glob Fl 15 g
Market launch
16/12/2021
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data